Here are some of the latest health and medical news
developments, compiled by the editors of HealthDay:
Perrigo Recalls Infant Pain and Fever Reliever
Safety concerns have prompted Perrigo to recall 18 batches of an
over-the-counter pain and fever reliever for infants that is sold
under brand names including Babies R Us and Care One.
The U.S.-wide recall covers batches of acetaminophen infant
suspension liquid, 160mg/5mL sold in 2 oz. and 4 oz. bottles
packaged with oral syringes. Some of the products may contain
syringes without dose markings, according to the U.S. Food and Drug
Using a syringe without dose markings could result in infants
receiving an incorrect dose of the medicine, the agency said.
Consumers who discover that the product has a syringe without
dose markings should not use the product. They should call Perrigo
at 1-800-719-9260 for more information, the FDA said.
Blood Test May Track Spread of Melanoma: Study
A simple blood test could detect if the deadly skin cancer
melanoma has spread, a new study says.
U.K. researchers found that measuring levels of a gene called
TFP12 in patients' DNA could be crucial,
"By using a blood test, we have the basis of a simple and accurate way of discovering how advanced the disease is, as well as an early warning sign of whether it has started to spread," study author Dr. Tim Crook said. "This would give doctors and patients important information much sooner than is possible at the moment."
"There's increasing evidence that the latest treatments are more effective in these early stages and, if we can identify patients whose cancer has only just started to spread, this would significantly improve the chances of beating the disease," said Crook, a consultant medical oncologist at the University of Dundee.
The findings, presented at a National Cancer Research Institute
meeting, could lead to faster diagnoses and new treatments,
according to Cancer Research U.K.,
Many Herbal Supplements Aren't What They Claim: Study
Many herbal supplements don't contain the type of plant that's
listed on the label, according to a new study.
Canadian researchers used a special DNA test to analyze 44
bottles of popular herbal supplements sold by 12 companies.
One-third of them had no trace of the plant they claimed to
The New York Timesreported.
Many of the products included ingredients that were not listed
on the label -- such as rice, soybean and wheat -- and were used as
fillers. In some products, these fillers were the only type of
plant detected in the supplement. That's a health concern for
people with allergies or those who believe they were buying
gluten-free products, said study lead author Steven Newmaster, a
biology professor and botanical director of the Biodiversity
Institute of Ontario at the University of Guelph.
The study in the journal
BMC Medicinelends support to previous studies that have
suggested a significant number of herbal products are not what they
claim to be,
An estimated 29,000 herbal products and substances are sold in
North America and Americans spend about $5 billion a year on such
These new findings suggest "that the problems are widespread and
that quality control for many companies, whether through ignorance,
incompetence or dishonesty, is unacceptable," David Schardt, a
senior nutritionist at the Center for Science in the Public
"Given these results, it's hard to recommend any herbal supplements to consumers," he added.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.